all report title image

GLYCOMICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Glycomics Market, By Product Type (Reagents, Enzymes, Kits, and Equipment), By Application (Diagnostics, Drug Discovery & Development, and Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, CROs, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In : Mar 2024
  • Code : CMI6796
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Key Developments

  • On March 11, 2024, Bruker Corporation announced progress in immunopeptidomics, glycoproteomics, and other Collision Cross Section (CCS) -enabled 4D proteomics workflows. Bruker Corporation's rapid developments in deep, at-scale proteomics, glycomics, and peptidomics research solutions complement its other performance-leading life-science technologies for the post-genomic era. Together, they enable post-genomic molecular and cell biology research, providing critical insights into disease biology and biomarkers for next-generation molecular diagnostics and medication development.
  • On January 30, 2024, Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, the leader in breakthrough in situ proximity ligation assay-based solutions, announced the signing of an agreement. This collaboration aims to create cutting-edge biomarker discovery techniques that will identify particular protein glycosylation in tissue samples for the first time.
  • In April 2021, BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, and the Canadian Glycomics Network (GlycoNet), a pan-Canadian Network of Centers of Excellence, announced a collaboration to translate glycomics research into potential treatments for patients with genetic diseases. BridgeBio Pharma, Inc. will collaborate with GlycoNet researchers to identify research projects that have the potential to become treatments for genetic illnesses.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.